Table 2. Metabolic Parameters at Baseline by HIV Status and Type of Contraceptive Use.
| HIV-infected | HIV-uninfected | |||||||
|---|---|---|---|---|---|---|---|---|
| Contraception | Contraception | |||||||
| Combined hormonal | Progestin-only | Non-hormonal or none | P-value | Combined hormonal | Progestin-only | Non-hormonal or none | P-value | |
| HDL (mg/dL) | 0.05 | 0.01 | ||||||
| <40 mg/dL | 14 (25) | 38 (45) | 333 (34) | - | 6 (10) | 10 (24) | 43 (10) | - |
| 40-59 mg/dL | 25 (46) | 35 (42) | 429 (44) | - | 29 (47) | 24 (59) | 220 (52) | - |
| ≥ 60 mg/dL | 16 (27) | 10 (12) | 207 (21) | - | 27 (44) | 7 (17) | 161 (38) | - |
| HOMA | 0.25 | 0.53 | ||||||
| ≤ 2.5 | 36 (69) | 45 (55) | 573 (60) | - | 44 (71 ) | 25 (63) | 258 (63) | - |
| >2.5 | 16 (31) | 37 (45) | 383 (40) | - | 18 (29) | 15 (38) | 146 (36) | - |
| Triglycerides (mg/dL) | 0.044 | 0.29 | ||||||
| < 150 mg/dL | 41 (75) | 58 (70) | 719 (74) | - | 57 (92) | 35 (85) | 382 (90) | - |
| 150 – 199 mg/dL | 6 (11) | 7 (8) | 144 (15) | - | 4 (6) | 2 (5) | 27 (6) | - |
| ≥ 200 mg/dL | 8 (15) | 18 (22) | 110 (11) | - | 1 (2) | 4 (10) | 15 (4) | - |
| LDL (mg/dL) | 0.13 | 0.26 | ||||||
| < 100 mg/dL | 22 (41) | 42 (49) | 506 (53) | - | 31 (50) | 19 (46) | 225 (53) | - |
| 100 – 129 mg/dL | 20 (37) | 20 (24) | 291 (31) | - | 25 (40) | 11 (27) | 130 (31) | - |
| 130 – 159 mg/dL | 11 (20) | 13 (15) | 111 (12) | - | 4 (6) | 9 (22) | 49 (12) | - |
| ≥ 160 mg/dL | 1 (2) | 6 (7) | 38 (4) | - | 2(3) | 2(5) | 20 (5) | - |
| Glucose (mg/dL) | 0.26 | 0.1 | ||||||
| < 100 mg/dL | 54 (98) | 77 (92) | 898 (92) | - | 55 (89) | 41 (100) | 390 (92) | - |
| 100 – 125 mg/dL | 1 (2) | 6 (7) | 76 (8) | - | 7 (11) | 0 | 34 (8) | - |